← Back to Screener
Anteris Technologies Global Corp. Common Stock (AVR)
Price$5.92
Favorite Metrics
Price vs S&P 500 (26W)22.92%
Price vs S&P 500 (4W)-1.10%
Market Capitalization$590.20M
All Metrics
Book Value / Share (Quarterly)$0.10
P/TBV (Annual)3.21x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-15.77%
Cash Flow / Share (Quarterly)$-1.92
Price vs S&P 500 (YTD)17.50%
Gross Margin (TTM)70.26%
Net Profit Margin (TTM)-4921.28%
EPS (TTM)$-2.54
10-Day Avg Trading Volume0.70M
EPS Excl Extra (TTM)$-2.54
EPS (Annual)$-2.55
ROI (Annual)-121.55%
Gross Margin (Annual)70.26%
Cash / Share (Quarterly)$0.30
Revenue Growth QoQ (YoY)-42.18%
ROA (Last FY)-409.38%
Revenue Growth TTM (YoY)46.58%
EBITD / Share (TTM)$-2.49
Operating Margin (TTM)-4908.21%
Cash Flow / Share (Annual)$-1.92
P/B Ratio159.60x
P/B Ratio (Quarterly)43.88x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)301.97x
Net Interest Coverage (TTM)-1057.71x
ROA (TTM)-267.57%
EPS Incl Extra (Annual)$-2.55
Current Ratio (Annual)0.73x
Quick Ratio (Quarterly)0.70x
3-Month Avg Trading Volume1.02M
52-Week Price Return112.98%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.10
P/S Ratio (Annual)308.52x
Asset Turnover (Annual)0.08x
52-Week High$6.95
EPS Excl Extra (Annual)$-2.55
26-Week Price Return31.67%
Quick Ratio (Annual)0.70x
13-Week Price Return34.59%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.73x
Enterprise Value$577.661
Asset Turnover (TTM)0.05x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.71x
Pretax Margin (Annual)-4925.51%
Cash / Share (Annual)$0.30
3-Month Return Std Dev66.62%
Net Income / Employee (TTM)$-1
ROE (Last FY)-121.56%
Net Interest Coverage (Annual)-117.08x
EPS Basic Excl Extra (Annual)$-2.55
Receivables Turnover (TTM)15.94x
Total Debt / Equity (Quarterly)0.04x
EPS Incl Extra (TTM)$-2.54
Receivables Turnover (Annual)15.94x
ROI (TTM)-247.42%
P/S Ratio (TTM)308.52x
Revenue / Share (Annual)$0.05
Tangible BV / Share (Annual)$1.74
Price vs S&P 500 (52W)77.89%
Year-to-Date Return21.64%
5-Day Price Return-2.10%
EPS Normalized (Annual)$-2.55
Net Profit Margin (Annual)-4921.28%
Month-to-Date Return9.37%
EBITD / Share (Annual)$-2.51
Operating Margin (Annual)-4908.21%
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.02x
EPS Basic Excl Extra (TTM)$-2.54
P/TBV (Quarterly)44.73x
P/B Ratio (Annual)3.20x
Inventory Turnover (TTM)1.72x
Pretax Margin (TTM)-4925.51%
Book Value / Share (Annual)$1.75
Price vs S&P 500 (13W)31.72%
Beta3.00x
Revenue / Share (TTM)$0.05
ROE (TTM)-249.90%
52-Week Low$2.64
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
AVRAnteris Technologies Global Corp. Common Stock | 308.52x | — | 70.26% | -4908.21% | $5.92 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
About
Anteris Technologies Global Corp develops minimally invasive medical devices for structural heart disease, with its DurAVR Transcatheter Heart Valve as the flagship product. The balloon-expandable valve treats aortic stenosis through a biomimetic design that mimics the performance of a healthy human aortic valve. The company operates primarily in the United States, with additional presence in Germany, Australia, Switzerland, and Sweden.